High-flow nasal cannula therapy: clinical practice in intensive care units.
Emmanuel BesnierSinad HobeikaSaad NSeirFabien LambiotteDamien Du CheyronBertrand SauneufBenoit MissetFabienne TamionGuillaume SchnellJack RichecoeurJulien MaizelChristophe Giraultnull nullPublished in: Annals of intensive care (2019)
HFNC is used by ICU physicians in many situations of ARF, despite their relatively low expectations of success, especially in cases of hypercapnia. Clinical practices appear somewhat heterogeneous. Despite the physiological benefit of HFNC, further prospective observational studies are still required on HFNC outcomes and daily practices.
Keyphrases
- primary care
- intensive care unit
- clinical practice
- healthcare
- mechanical ventilation
- extracorporeal membrane oxygenation
- physical activity
- respiratory failure
- acute respiratory distress syndrome
- stem cells
- mesenchymal stem cells
- type diabetes
- positive airway pressure
- skeletal muscle
- adipose tissue
- chemotherapy induced